Literature DB >> 11822820

Using salivary glands as a tissue target for gene therapeutics.

A T Hoque1, S Yamano, L Baccaglini, B J Baum.   

Abstract

Gene transfer offers a potential way to correct local and systemic protein deficiency disorders by using genes as drugs, so called gene therapeutics. Salivary glands present an interesting target site for gene therapeutic applications. Herein, we review proofs of concept achieved for salivary glands with in vivo animal models. In that context we discuss problems (general and salivary tissue-specific) that limit immediate clinical use for this application of gene transfer. Ongoing efforts, however, suggest that salivary glands may be suitable as gene therapeutic target sites for drug delivery in the near future.

Entities:  

Mesh:

Year:  2001        PMID: 11822820     DOI: 10.3109/10611860108998782

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  2 in total

1.  Isoproterenol increases sorting of parotid gland cargo proteins to the basolateral pathway.

Authors:  Srirangapatnam G Venkatesh; Jinlian Tan; Sven-Ulrik Gorr; Douglas S Darling
Journal:  Am J Physiol Cell Physiol       Date:  2007-05-30       Impact factor: 4.249

2.  Salivary PYY: a putative bypass to satiety.

Authors:  Andres Acosta; Maria D Hurtado; Oleg Gorbatyuk; Michael La Sala; David Duncan; George Aslanidi; Martha Campbell-Thompson; Lei Zhang; Herbert Herzog; Antonis Voutetakis; Bruce J Baum; Sergei Zolotukhin
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.